Navigation Links
Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
Date:7/25/2011

PRINCETON, N.J., July 25, 2011 /PRNewswire/ -- Laureate Biopharmaceutical Services, Inc., a full-service biopharmaceutical contract development and manufacturing organization, today announced that they have entered into a multi-year development and manufacturing agreement with a leading generic pharmaceutical company to produce a biosimilar product.  Laureate's services will include transfer of the manufacturing process to Laureate and cGMP manufacture of this product for clinical trials through 2013. The agreement includes a customer option for long-term commercial supply.  Laureate expects to supply the first batch of clinical product during the first half of 2012.  Terms of the manufacturing agreement were not disclosed.

"Biosimilars are the immediate growth engine of the generic industry and we are pleased to be working with one of the leading generic companies in the world on this product," said Michael A. Griffith, CEO of Laureate Biopharma. "Manufacture of biosimilars is one natural extension of Laureate's existing portfolio of contract manufacturing services and represents a key strategic step for the company."  

About Biosimilars

Biosimilars are subsequent versions of recombinant therapeutic innovator products manufactured and sold by a different corporate sponsor following expiry of patent exclusivity for the innovator product.  With many innovator biopharmaceutical products going off patent in the next 5-10 years, there is an industry-wide effort to develop corresponding biosimilars. The U.S. FDA was given the authority to approve biosimilars within the Patient Protection and Affordable Care Act of 2010, following similar approvals in the European Union.  

About Laureate Biopharmaceutical Services, Inc.

Laureate Biopharmaceutical Services, Inc. is a full-service biopharmaceutical contract development and manufacturing organization. Laureate Biopharma's scientists are expert
'/>"/>

SOURCE Laureate Biopharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Laureates Electronic Submission Gateway Approved
2. Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.
3. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
4. Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals Antibody Therapeutic
5. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
6. Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
7. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
8. Thomson Reuters Predicts Nobel Laureates
9. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
10. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
11. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... CHAPEL HILL, N.C. , July 25, 2014 /PRNewswire/ ... of challenges, including understanding new advancements in technology and ... top of this, libraries in the pharmaceutical and medical ... the value of the information and services they provide. ... firm, Best Practices, LLC there are many forces of ...
(Date:7/25/2014)... , July 25, 2014  In today,s marketplace, ... costly and challenging - as is managing a portfolio ... Is it possible - or even preferable - ... so, where can you combine resources and activities, and ... These are just a few of the ...
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... the nation seeks to expand health care coverage ... from Harvard University, Brigham and Women,s Hospital and ... that preventative health care may be significantly less ... of cost-effective generic medications for the treatment and ...
... July 7, 2011 ,   ... Yttrium-90 Resin Microspheres (ENRY),analysis of the long-term outcomes related ... with inoperable,primary liver tumours were published on-line today in, ... the Study of Liver,Diseases. [ 1 ] ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 2CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 3CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 4Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 2Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 3Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 4Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 5
(Date:7/25/2014)... AttorneyOne.com, a recognized authority on law, update ... FDA on Ibuprofen and Oxcarbazepine Tablets . , ... Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health ... Oxcarbazepine is used for the treatment of certain types of ... for the recall is that Lot #142588, Expiration Date, 01/2016 ...
(Date:7/25/2014)... A new study of participants in the National Lung ... in Cancer , found evidence that men and women ... abnormal finding on a lung cancer screening test did not ... those who were screened and found to be cancer-free. ... “We expected that participants with an abnormal finding would be ...
(Date:7/25/2014)... TX (PRWEB) July 25, 2014 ... the current state of the Galactooligosaccharides (GOS) ... a basic overview of the industry, including definitions, ... and Chinese domestic market analysis are provided with ... landscape of the market. A comparison between the ...
(Date:7/25/2014)... 2014 (HealthDay News) -- Shift workers, especially men, may be ... not on such schedules, a new study suggests. Also ... a set schedule, with shifts moving around at various times ... surprising," said one expert, Dr. Alan Manevitz, a clinical psychiatrist ... have long known that working shifts disrupts many key body ...
(Date:7/25/2014)... sent patients to designated cardiac receiving centers dramatically increased ... in Arizona, according to a study published online yesterday ... , "We knew lives would be saved if the ... arrest care and we were able to get cardiac ... done for Level 1 trauma patients," said lead study ...
Breaking Medicine News(10 mins):Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 2Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 3
... News) -- Scientists believe they,ve discovered how HIV triggers the ... in turn leads to AIDS. It was believed that ... not actually infected, a situation labeled "bystander cell killing." ... "bystander" cells die because of a failed or abortive HIV ...
... of your love for your mate as the noble emotion ... brain are taking a decidedly more pragmatic approach to the ... cichlid fish, the scientists discovered that when a female shows ... losing a fight with another male, her feelings toward him ...
... Nov. 24 (HealthDay News) -- If you are one of ... gatherings, a few simple steps can help reduce your stress ... Decker School of Nursing at Binghamton University, State University of ... perishable items well ahead of time and have a list ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... good predictor of academic performance, but not necessarily in ... the IQs and reading, spelling and math abilities of ... children,s social functioning through parental and teacher reports at ...
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) -- With ... many Americans will soon be subjected to radiation-emitting body scanners ... concerns and complaints in recent weeks over body scanners, most ... low to pose any serious health threat. Peter Rez, ...
... 2010) - Even though most people are aware that good ... mother and child, misunderstandings about the safety of dental care ... dentist. The fact is that dentists can create a treatment ... adverse effects of oral disease during pregnancy. During the ...
Cached Medicine News:Health News:Scientists May Have Solved an HIV Mystery 2Health News:Female fish -- and humans? -- lose interest when their male loses a slugfest 2Health News:Female fish -- and humans? -- lose interest when their male loses a slugfest 3Health News:Female fish -- and humans? -- lose interest when their male loses a slugfest 4Health News:For Autistic Kids, IQ May Not Predict School Achievement 2Health News:For Autistic Kids, IQ May Not Predict School Achievement 3Health News:Airport Body Scanners Safe, Experts Say 2Health News:Airport Body Scanners Safe, Experts Say 3Health News:Expecting? Don't neglect your teeth 2
... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
Inquire...
Chemically Resistant Sealing Mat for 384ch, Square Well Available Sterile...
Medicine Products: